脑部放疗，上午比下午敏感许多！
9 {9 x$ v# |" t. B0 \! Q; m0 ^2 J8 s) Q$ r& b9 |- e8 Z
, |, s) T3 S8 X! ]( OCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
, o/ d! c: Q3 u7 N9 JGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?6 I- z% }3 j0 c$ t, j
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.1 x W, ~) o% [" `# t# m R1 N
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.* p2 N' t4 D$ r3 ?7 |
3 C! E& p3 ^. f, d0 }7 t
Abstract: N; i8 v$ S& Y
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) g5 d0 c3 X9 k" S( D
) B4 C- N( v4 ~) T* Y PMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
* u. @4 l8 L3 U# _2 C2 l$ x. {* k4 W4 w3 r6 G& f7 I& K" |: C% J' E
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).9 v; ^2 b% _# j/ }
* \4 K* E5 b8 w2 W9 E$ \
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
! M g8 J+ Z1 d5 f" m
( h$ O3 X# F: w& K" W1 E0 @ |
6 N7 o( P1 G2 s1 l
显身卡
